Huang S.-H.Yang C.-J.CHIEN-CHING HUNG2021-12-012021-12-0120200270-9139https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078797396&doi=10.1002%2fhep.30976&partnerID=40&md5=4b0217114c99c874b36368f8c1fca5f3https://scholars.lib.ntu.edu.tw/handle/123456789/588725[SDGs]SDG3hepatitis A antibody; hepatitis A vaccine; CD4 lymphocyte count; hepatitis A; Hepatitis A virus; human; Human immunodeficiency virus infected patient; infection risk; Letter; priority journal; vaccination; hepatitis A; Human immunodeficiency virus; incidence; Hepatitis A; HIV; Humans; Incidence; Vaccinationletter10.1002/hep.30976315667722-s2.0-85078797396